Genomic Markers New Biomarker Identified: TAA Burden Could Predict Immunotherapy Success in Cancer Patients Lacking Traditional Markers
Genomic Markers Intragenic rearrangement burden: Broadening Access to Immunotherapy Through Innovative Genetic Testing
